Cargando…
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences
Funding and gifts from the pharmaceutical industry have an influence on the decisions made by physicians and medical experts. In the context of the coronavirus disease 2019 epidemic, several treatments are available to treat patients infected with the virus. Some are protected by patents, such as re...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558214/ https://www.ncbi.nlm.nih.gov/pubmed/33088575 http://dx.doi.org/10.1016/j.nmni.2020.100710 |
_version_ | 1783594591206768640 |
---|---|
author | Roussel, Y. Raoult, D. |
author_facet | Roussel, Y. Raoult, D. |
author_sort | Roussel, Y. |
collection | PubMed |
description | Funding and gifts from the pharmaceutical industry have an influence on the decisions made by physicians and medical experts. In the context of the coronavirus disease 2019 epidemic, several treatments are available to treat patients infected with the virus. Some are protected by patents, such as remdesivir, others0020stare not, such as hydroxychloroquine. We wanted to observe the possible correlation between the fact, for an academic doctor in infectious diseases, of having benefited from funding by Gilead Sciences, producer of remdesivir, and the public positions taken by this doctor towards hydroxychloroquine. Our results show a correlation (Spearman test, p = 0.017) between the amount received from the Gilead Sciences company and public opposition to the use of hydroxychloroquine in France. This should open up the debate on the role of the interest links of doctors with pharmaceutical companies in the medical and scientific public debate. |
format | Online Article Text |
id | pubmed-7558214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75582142020-10-20 Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences Roussel, Y. Raoult, D. New Microbes New Infect Original Article Funding and gifts from the pharmaceutical industry have an influence on the decisions made by physicians and medical experts. In the context of the coronavirus disease 2019 epidemic, several treatments are available to treat patients infected with the virus. Some are protected by patents, such as remdesivir, others0020stare not, such as hydroxychloroquine. We wanted to observe the possible correlation between the fact, for an academic doctor in infectious diseases, of having benefited from funding by Gilead Sciences, producer of remdesivir, and the public positions taken by this doctor towards hydroxychloroquine. Our results show a correlation (Spearman test, p = 0.017) between the amount received from the Gilead Sciences company and public opposition to the use of hydroxychloroquine in France. This should open up the debate on the role of the interest links of doctors with pharmaceutical companies in the medical and scientific public debate. Elsevier 2020-06-06 /pmc/articles/PMC7558214/ /pubmed/33088575 http://dx.doi.org/10.1016/j.nmni.2020.100710 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Roussel, Y. Raoult, D. Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
title | Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
title_full | Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
title_fullStr | Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
title_full_unstemmed | Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
title_short | Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
title_sort | influence of conflicts of interest on public positions in the covid-19 era, the case of gilead sciences |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558214/ https://www.ncbi.nlm.nih.gov/pubmed/33088575 http://dx.doi.org/10.1016/j.nmni.2020.100710 |
work_keys_str_mv | AT roussely influenceofconflictsofinterestonpublicpositionsinthecovid19erathecaseofgileadsciences AT raoultd influenceofconflictsofinterestonpublicpositionsinthecovid19erathecaseofgileadsciences |